Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-24

Clinical Trial Update: Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA) [Phase 4]

View source ↗

Summary

Phase 4 trial assessing paracetamol's effect on brain BOLD fMRI signals in adults with osteoarthritis of the knee; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paracetamol (acetaminophen)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Osteoarthritis, Knee | Phase 4 | Status: COMPLETED | Results posted: 2015-03-24